Victor L. Thijssen

Galectin-1 is essential in tumor angiogenesis and is a target for antiangiogenesis therapy

Victor L. Thijssen, Ruben Postel, Ricardo Brandwijk et al. · Proceedings of the National Academy of Sciences · 2006 · 480 citations · Full text

Angiogenesis, Antiangiogenesis Therapy, Medicine +11

Anti‐angiogenesis therapy can overcome endothelial cell anergy and promote leukocyte‐endothelium interactions and infiltration in tumors

Anita E M Dirkx, Mirjam G.A. oude Egbrink, Karolien Castermans et al. · The FASEB Journal · 2006 · 264 citations

Immunology, Tumor Escape, Immunotherapy +19

Tumor Cells Secrete Galectin-1 to Enhance Endothelial Cell Activity

Victor L. Thijssen, Batya Barkan, Hiroki Shoji et al. · Cancer Research · 2010 · 239 citations · Full text

Immunology, Tumor Endothelial Cells, Cancer Biology +19

Antiangiogenesis Therapy for Endometriosis

Annemiek Nap, Arjan W. Griffioen, Gerard A.J. Dunselman et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 235 citations

Gynecology, Pathology, Menstrual Cycle +16

The Galectin Profile of the Endothelium

Victor L. Thijssen, Sarah Hulsmans, Arjan W. Griffioen · American Journal Of Pathology · 2008 · 205 citations · Full text

Inflammation, Physiology, Immunology +7